Date published: 2026-1-12

001 800-1338-3838

SCBT Portrait Logo
Seach Input

pelota アクチベーター

If such a class were to be recognized, it would imply a group of chemical compounds specifically designed to modulate the activity of the biological entity termed 'pelota'. Assuming 'pelota' refers to a protein or biochemical pathway, activators of this class would interact with the 'pelota' entity to enhance its biological function. This could be through direct binding to the protein, which may stabilize it in an active conformation, or by facilitating its interaction with other proteins or substrates. The nature of these activators would be determined by the structural requirements of the 'pelota' binding sites, leading to a diverse array of molecular structures, possibly encompassing small organic compounds, peptides, or other biologically active molecules, each with specific affinities and selectivities towards their target.

The identification and development of 'pelota Activators' would involve a combination of computational chemistry and experimental biology. Initially, a detailed understanding of the 'pelota' structure and function would be required, which could be gleaned from X-ray crystallography, NMR spectroscopy, or cryo-electron microscopy data. With this information, virtual screening processes could be employed to identify potential activator compounds, which would then be synthesized and assessed for their ability to enhance 'pelota' activity. Biochemical assays would be crucial for this assessment, testing the effects of these compounds on the activity of 'pelota' in vitro. Such assays would likely include activity measurements in the presence of substrate molecules or binding studies to determine the affinity and kinetics of interaction between the 'pelota' protein and the activators. The results of these experiments would inform further optimization of the compounds, potentially leading to the development of a diverse chemical class of 'pelota Activators'. However, it is important to note that this concept is speculative and is not based on current scientific consensus or literature.

関連項目

製品名CAS #カタログ #数量価格引用文献レーティング

Cycloheximide

66-81-9sc-3508B
sc-3508
sc-3508A
100 mg
1 g
5 g
$41.00
$84.00
$275.00
127
(6)

真核生物のタンパク質合成を阻害し、PELOのようなリボソームリサイクル因子をアップレギュレートするストレス応答につながる可能性がある。

Puromycin dihydrochloride

58-58-2sc-108071
sc-108071B
sc-108071C
sc-108071A
25 mg
250 mg
1 g
50 mg
$42.00
$214.00
$832.00
$66.00
394
(15)

タンパク質合成時に早すぎる鎖切断を引き起こし、リボソームリサイクル機構の必要性を高める可能性がある。

Anisomycin

22862-76-6sc-3524
sc-3524A
5 mg
50 mg
$99.00
$259.00
36
(2)

ペプチド結合の形成を阻害することでタンパク質合成を阻害し、PELOをアップレギュレートする細胞反応を引き起こす可能性がある。

Chloramphenicol

56-75-7sc-3594
25 g
$90.00
10
(1)

細菌のリボソームに結合し、タンパク質合成を阻害するため、それに反応してリボソーム関連タンパク質の発現が促進される可能性がある。

Actinomycin D

50-76-0sc-200906
sc-200906A
sc-200906B
sc-200906C
sc-200906D
5 mg
25 mg
100 mg
1 g
10 g
$74.00
$243.00
$731.00
$2572.00
$21848.00
53
(3)

DNAにインターカレートしてRNA合成を阻害するため、間接的にタンパク質合成経路に影響を与え、PELOの発現に影響を与える可能性がある。

Emetine

483-18-1sc-470668
sc-470668A
sc-470668B
sc-470668C
1 mg
10 mg
50 mg
100 mg
$440.00
$900.00
$1400.00
$2502.00
(0)

トランスロケーションを阻害することでタンパク質合成を阻害し、リボソームリサイクリングタンパク質の発現を増加させる可能性がある。

Tetracycline

60-54-8sc-205858
sc-205858A
sc-205858B
sc-205858C
sc-205858D
10 g
25 g
100 g
500 g
1 kg
$63.00
$94.00
$270.00
$417.00
$634.00
6
(1)

細菌におけるタンパク質合成を阻害し、ストレスへの反応としてリボソームレスキュー因子のアップレギュレーションを間接的に引き起こす可能性がある。

α-Amanitin

23109-05-9sc-202440
sc-202440A
1 mg
5 mg
$269.00
$1050.00
26
(2)

RNAポリメラーゼIIを阻害し、mRNA合成に影響を与え、間接的にリボソームリサイクリングタンパク質レベルの変化につながる可能性がある。